26 Oct, 2017 The impact of Brexit on regulation in the life sciences sector By DLA Piper The House of Lords Science and Technology Committee's inquiry into "Life Sciences and the Industrial Strategy" is fascinating. Last week...
26 Oct, 2017 Spanish nurses will apply drugs without prior green light from doctors By Diego Ramos Good news at last. Spanish Nurses and Doctors associations have reached a deal, brokered by the Spanish Ministry of Public Health, to...
23 Oct, 2017 EMA Relocation: an update By Roberto Valenti In the near future the European Medicines Agency (EMA), the agency responsible for the scientific evaluation, supervision and safety...
20 Oct, 2017 Tackling the Gender Pay Gap By Kate Hodgkiss The clock is ticking on the requirement for all employers with more than 250 employees to publish details of their gender pay gap. Data...
20 Oct, 2017 Further assurances welcomed By Kate Hodgkiss As further talks get underway in Europe, the need to provide clarity to employers and EU employees re-enters the spotlight. Whilst the...
18 Oct, 2017 Transforming business IP creation and protection By DLA Piper In a fascinating talk by Dr Stephan Wolke CEO of Thyssenkrupp at the C5 Life Sciences Summit in Munich last week, Dr Wolke shared his...
14 Oct, 2017 Innovator Friendly UK Post Brexit By DLA Piper As the clock continues to tick on Brexit, the UK is shaping up to be innovator friendly post Brexit. The UK Life Sciences Industry...